Celladon Corporation Completes Second Close of Recent Venture Financing MarketWatch (press release) Together, we will progress the continued development of MYDICAR for patients with advanced Heart Failure," said Krisztina Zsebo Ph.D., President and CEO of Celladon Corp. The previously announced results of the phase 2 CUPID Trial met its primary ... |
